1:00 p.m. | Registration
1:30 p.m. | Welcome Remarks
1:40 p.m. | Research fire-side chat: State of the scientific landscape
- Judy Lieberman - Professor Harvard, Boston Children
- Moderator: Uciane Scarlett - Principal, MPM Capital
2:20 p.m. | Innovation Bridge presentation: New Modalities at the Crossroads
- Dennis Chang - Managing Partner Clarion
2:50 p.m. | Innovation debate-style panel: Spectrum of new modalities
- Sandra Glucksmann - CEO, Cedilla Therapeutics
- Tom Barnes - CEO, Orna
- Keith Flaherty - Professor, MGH; Co-founder Loxo Oncology, Scorpion Therapeutics
- Anna Protopapas - CEO, Mersana
- Arjun Goyal - Co-founder, Partner Vida Ventures
- Reid Huber - Partner, Third Rock Ventures
- Moderator: Prashant Girinath - Partner, Greenberg Traurig
3:30 p.m. | People round table: Skills required to translate and implement
- Rosana Kapeller - CEO, Rome Therapeutics
- Doug Williams - CEO, Codiak
- Marian Nakada - VP, JJDC
- Luba Greenwood - CEO, Kojin Therapeutics
- Moderator: Luke Timmerman - Founder, Editor, Timmerman Report
4:10 p.m. | Closing Remarks
- Luke Timmerman & Life Science Cares
4:30 – 8 p.m. | MPM hosted Reception